AAAAAA

   
Results: 1-11 |
Results: 11
Schedule-dependent pharmacodynamic effects of gemcitabine and cisplatin inmice bearing Lewis lung murine non-small cell lung tumours
Authors: van Moorsel, CJA Pinedo, HM Smid, K Comijn, EM Voorn, DA Veerman, G Lakerveld, B Van der Vijgh, WJF Giaccone, G Postmus, PE Peters, GJ
Citation: Cja. Van Moorsel et al., Schedule-dependent pharmacodynamic effects of gemcitabine and cisplatin inmice bearing Lewis lung murine non-small cell lung tumours, EUR J CANC, 36(18), 2000, pp. 2420-2429
Cross-resistance in the 2 ',2 '-difluorodeoxycytidine (gemcitabine)-resistant human ovarian cancer cell line AG6000 to standard and investigational drugs
Authors: Bergman, AM Giaccone, G van Moorsel, CJA Mauritz, R Noordhuis, P Pinedo, HM Peters, GJ
Citation: Am. Bergman et al., Cross-resistance in the 2 ',2 '-difluorodeoxycytidine (gemcitabine)-resistant human ovarian cancer cell line AG6000 to standard and investigational drugs, EUR J CANC, 36(15), 2000, pp. 1974-1983
Differential effects of gemcitabine on ribonucleotide pools of twenty-one solid tumour and leukaemia cell lines
Authors: van Moorsel, CJA Bergman, AM Veerman, G Voorn, DA van Haperen, VWTR Kroep, JR Pinedo, HM Peters, GJ
Citation: Cja. Van Moorsel et al., Differential effects of gemcitabine on ribonucleotide pools of twenty-one solid tumour and leukaemia cell lines, BBA-GEN SUB, 1474(1), 2000, pp. 5-12
Basis for effective combination cancer chemotherapy with antimetabolites
Authors: Peters, GJ van der Wilt, CL van Moorsel, CJA Kroep, JR Bergman, AM Ackland, SP
Citation: Gj. Peters et al., Basis for effective combination cancer chemotherapy with antimetabolites, PHARM THERA, 87(2-3), 2000, pp. 227-253
Scheduling of gemcitabine and cisplatin in Lewis Lung tumour bearing mice
Authors: van Moorsel, CJA Pinedo, HM Veerman, G Vermorken, JB Postmus, PE Peters, GJ
Citation: Cja. Van Moorsel et al., Scheduling of gemcitabine and cisplatin in Lewis Lung tumour bearing mice, EUR J CANC, 35(5), 1999, pp. 808-814
Selective cell kill of the combination of gemcitabine and cisplatin in multilayered postconfluent tumor cell cultures
Authors: Padron, JM van Moorsel, CJA Bergman, AM Smitskamp-Wilms, E van der Wilt, CL Peters, GJ
Citation: Jm. Padron et al., Selective cell kill of the combination of gemcitabine and cisplatin in multilayered postconfluent tumor cell cultures, ANTI-CANC D, 10(5), 1999, pp. 445-452
Pharmacokinetic schedule finding study of the combination of gemcitabine and cisplatin in patients with solid tumors
Authors: van Moorsel, CJA Kroep, JR Pinedo, HM Veerman, G Voorn, DA Postmus, PE Vermorken, JB van Groeningen, CJ van der Vijgh, WJF Peters, GJ
Citation: Cja. Van Moorsel et al., Pharmacokinetic schedule finding study of the combination of gemcitabine and cisplatin in patients with solid tumors, ANN ONCOL, 10(4), 1999, pp. 441-448
Gemcitabine-cisplatin: A schedule finding study
Authors: Kroep, JR Peters, GJ van Moorsel, CJA Catik, A Vermorken, JB Pinedo, HM van Groeningen, CJ
Citation: Jr. Kroep et al., Gemcitabine-cisplatin: A schedule finding study, ANN ONCOL, 10(12), 1999, pp. 1503-1510
Gemcitabine and paclitaxel: Pharmacokinetic and pharmacodynamic interactions in patients with non-small-cell lung cancer
Authors: Kroep, JR Giaccone, G Voorn, DA Smit, EF Beijnen, JH Rosing, H van Moorsel, CJA van Groeningen, CJ Postmus, PE Pinedo, HM Peters, GJ
Citation: Jr. Kroep et al., Gemcitabine and paclitaxel: Pharmacokinetic and pharmacodynamic interactions in patients with non-small-cell lung cancer, J CL ONCOL, 17(7), 1999, pp. 2190-2197
Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines
Authors: van Moorsel, CJA Pinedo, HM Veerman, G Bergman, AM Kuiper, CM Vermorken, JB van der Vijgh, WJF Peters, GJ
Citation: Cja. Van Moorsel et al., Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines, BR J CANC, 80(7), 1999, pp. 981-990
Combination chemotherapy studies with gemcitabine and etoposide in non-small cell lung and ovarian cancer cell lines
Authors: van Moorsel, CJA Pinedo, HM Veerman, G Guechev, A Smid, K Loves, WJP Vermorken, JB Postmus, PE Peters, GJ
Citation: Cja. Van Moorsel et al., Combination chemotherapy studies with gemcitabine and etoposide in non-small cell lung and ovarian cancer cell lines, BIOCH PHARM, 57(4), 1999, pp. 407-415
Risultati: 1-11 |